Considering Antiviral Treatment to Preserve Hearing in Congenital CMV.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. American Cochlear Implant Alliance Position Statement on Newborn Congenital Cytomegalovirus Screening.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
   Guideline
2. [Chances and challenges in the prevention and treatment of early childhood hearing loss: the AWMF guideline on congenital CMV infection].HNO · 2026
   Review
3. Congenital Cytomegalovirus Infection: From Silent Threat to Vaccine Horizon.Vaccines · 2025
   Review
4. Congenital Cytomegalovirus and Hearing Loss: The State of the Art.Journal of clinical medicine · 2023
   Review
5. Prevalence of asymptomatic cytomegalovirus (CMV) infection in newborns in northeast Florida.Frontiers in epidemiology · 2023
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as